Innovations Abound - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Innovations Abound

Pharmaceutical Technology

Here's a look at some of the most interesting and thematic responses you—our readers—provided for Pharmaceutical Technology's anniversary survey of industry advances and directions.

Which events significantly affected or caused changes in pharmaceutical manufacturing?
"My graduation from college."

"Better chemistry," "gene technology," and "train(ing) dogs to sniff counterfeit drugs" will impact the future direction of pharmaceutical manufacturing.

The rationalization of small-molecule manufacturing facilities in APIs.
"Is the leading edge of pharma."

On the use of information technology:
"There is no replacement for an advanced and validated computerized system."

When it comes to formulation development and manufacturing practices.
"The advice from our management is to have 50% of our workload outsourced—and especially routine work."

Thanks to advanced analytical technologies in NIR.
"(we) don't actually need to prepare the sample tediously."

With regard to the GMPs for the 21st century.
"It's been a long time since 1978, and it is time to update."

"...Most companies have found a way around..."
21 CFR Part 11 regulation.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Source: Pharmaceutical Technology,
Click here